|

BOOK
EXCERPT A Complete Surgical Guide for Correcting
Astigmatism James P. Gills, M.D.
CHAPTER
THREE Treating Astigmatism With Conductive
Keratoplasty Jason E. Stahl, MD; and Daniel S. Durrie, MD
In 1898, Lans published animal experiments documenting that
heating the peripheral cornea could induce central steepening.1 His
findings were supported by others in the early 20th century.2-4 The
result of these reports helped demonstrate that it was possible to surgically
alter the shape of the astigmatic cornea by steepening the flat axis by
shrinking the collagen of the cornea with heat, a procedure called thermal
keratoplasty.
In 1964, Stringer and Parr5 reported that the
disintegration of the helical structure of corneal collagen occurs when heated
to approximately 55° to 58° C. This breakdown in the collagen structure
allows the individual collagen fibers to contract by as much as one third of
their original size. This contraction results in localized shrinking of
collagen in the areas where heat is applied, thereby reshaping of the corneal
curvature. On this basis, application of heat to the peripheral cornea would
induce steepening of the central cornea.
Several thermal keratoplasty techniques for shrinking
peripheral corneal collagen have been attempted to steepen the central cornea
for refractive indications. In the 1980s, Fyodorov and collaborators evaluated
the use of a wire heated up to 600° C and inserted into the cornea at up to
95% depth to treat hyperopia.6-9 The extreme temperatures and
non-uniform heating of the corneal stroma resulted in stromal necrosis, poor
predictability, and substantial regression of the initial effect.
10-11
Mainster12 theorized that laser thermal
keratoplasty (LTK) would deliver heat to the stroma in a more uniform fashion
with less damage to the epithelium and endothelium. In the early 1990s, the
first contact probe holmium yttrium-aluminum-garnet (Ho:YAG) LTK procedure
(Summit Technology, Waltham, Mass) was developed.13 FDA clinical
trials of Summit contact LTK demonstrated poor predictability and regression of
effect. Non-contact Ho:YAG LTK (Sunrise Technologies, Fremont, Calif) was
approved for the treatment of hyperopia in 2000. The initial overcorrection and
significant regression of effect have been problematic for this technique.
Diode LTK (Prolaser Medical Systems, Inc, Dusseldorf, Germany) has demonstrated
effective ness to steepen the cornea in animal, cadaver, and blind
eyes.14-16
Conductive keratoplasty, or CK (Refractec, Inc, Irvine,
Calif), is a new thermokeratoplasty technology that received FDA approval in
April 2002 for the correction of 0.75 D to 3.00 D of hyperopia. CK utilizes
radiofrequency waves to shrink collagen and is currently under investigation
for the treatment of astigmatism.
|
 Figure 3-1. ViewPoint CK system: Console, probe, and
specula. Photo courtesy of Refractec, Inc.
|
 Figure 3-2. CK probe inserted into previously
placed corneal marks on the midperipheral cornea. Photo courtesy of Refractec,
Inc.
|
|
 Figure
3-3. Nomogram for the correction of 0.75 D to 3.0 D of astigmatism. The
nomogram is indicated within each circle with the sequence application shown on
the right.
|
CK, developed by Mendez,17 is a laserless
thermokeratoplasty technique that uses radiofrequency energy to shrink stromal
collagen. The ViewPoint CK system (Figure 3-1) (Refractec, Inc, Irvine, Calif)
uses a probe (Figure 3-2) to deliver low energy, high frequency (350 kHz)
current directly into the midperipheral corneal stroma at eight to 32 treatment
spots (Figure 3-3). Striae form between the spots (Figures 3-4a and 3-4b),
producing a band of tightening that increases the central corneal curvature,
thereby reducing spherical hyperopia (Figure 3-5).
|
 Figure 3-4a. Slit lamp photo of CK spots with
striae.
|
 Figure 3-4b. Slit lamp photo of CK spots with
striae.
|
|
 Figure 3-5. CK produces a band of tightening that
increases the central corneal curvature reducing hyperopia.
|
 Figure 3-6. The CK probe with Keratoplast tip (90 µm
wide, 450 µm long) with coated stop at the distal end (shown next to a
7-0 suture). Photo courtesy Refractec, Inc.
|
CK utilizes the unique conductive properties of the cornea.
As the current flows through the tip, the surrounding corneal tissue creates
resistance to the energy resulting in gentle, well-controlled homogenous heat
production. The stainless steel Keratoplast tip (Refractec, Inc, Irvine, Calif)
(Figure 3-6), with a diameter of 90 µm and length of 450 µm,
penetrates the cornea, delivering the current equally from corneal surface to
the end of the tip. The collagen surrounding the entire length of the tip is
exposed to the same temperature, creating a column or cylindrical footprint
that extends deep into the stroma at approximately 80% depth (Figures 3-7a and
3-7b).
 |
 |
|
Figure 3-7 a & b. Pig
cornea histology 1 week after treatment shows a CK spot with a cylindrical
footprint approximately 80% of corneal thickness. |
|
In contrast, the Ho:YAG LTK procedures apply pulsed infrared
energy onto the corneal surface producing an axial gradient with the highest
temperatures at the corneal surface. These techniques result in a cone-shaped
footprint13,18 at only approximately 50% of corneal
depth.18 The leading criticism of the Sunrise LTK technique has been
the regression of the initial effect. A comparison of stability values for CK
and Sunrise LTK suggests that less regression occurs with CK and that stability
is achieved earlier with CK.19 These results may be attributed to
the deeper cylindrical collagen shrinkage that is achieved with CK.
The shape and depth of the footprint of collagen shrinkage
techniques appears to be extremely important for the long-term stability of
these procedures. We were interested in evaluating the CK and LTK footprints in
patients 12 months after surgery. We performed ultrasound biomicroscopy (UBM)
studies on these patients 1 year after CK and LTK. The UBM of the CK spots
(Figure 3-8) shows a deep cylindrical footprint while the LTK spots (Figure
3-9) show a shallow conical footprint.
|
 Figure
3-8. UBM of CK spot 12 months postoperative with the arrow indicating the
deep cylindrical footprint. |
 Figure
3-9. UBM of LTK spot 12 months postoperative with arrow indicating the
shallow conical footprint.
|
The FDA has approved CK for the temporary reduction of
spherical hyperopia in patients who have 0.75 D to 3.25 D of cycloplegic
spherical hyperopia with less than 0.75 D of refractive astigmatism (minus
cylinder) and a cycloplegic spherical equivalent of +0.75 D to +3.00 D.
Patients must be 40 years of age or older with a documented stability of
refraction for the prior 12 months, as demonstrated by a change of less than
0.50 D in spherical and cylindrical components of manifest refraction.
Potential off-label applications of the CK technology
include the treatment of astigmatism, presbyopia, over- or undercorrections
following photorefractive keratectomy (PRK) and laser-assisted in situ
keratomileusis (LASIK), and finally refining post-cataract outcomes.
The principles of astigmatic keratotomy (AK) are well known
to corneal surgeons. AK incisions placed across the steep corneal meridian
(paralleling the axis of plus-cylinder refraction) causes relaxation of the
collagen that results in central flattening of that meridian and steepening of
the unincised meridian 90 degrees away. These incisions weaken the cornea
leaving it susceptible to rupture with trauma.
Compression sutures placed in the flat meridian (paralleling
the axis of minus-cylinder refraction) demonstrate that tightening collagen
causes central steepening of that meridian. Theoretically, a thermokeratoplasty
procedure that places treatment spots on the flat meridian would correct
astigmatism by tightening the collagen, resulting in central steepening of that
meridian.
Holmium:YAG laser thermokeratoplasty for the correction of
astigmatism has been evaluated by Thompson.20 He reported the
6-month results of the FDA phase 1 clinical trial for the correction of
astigmatism from 1.5 D to 4 D with the Summit contact LTK device. Twenty-six
eyes were treated with two LTK spots placed on each side of the flat meridian
at the 8.5-mm optical zone. The astigmatic correction ranged from 0.4 D to 3.98
D with a mean correction of 1.69 D. Thompson noted a trend toward greater
astigmatic correction with increasing age and toward a myopic shift in the
spherical equivalent. He reported the regression of astigmatic LTK was greater
than that seen with hyperopic corrections. We speculate that the regression of
effect was likely related to the cone-shaped footprint produced by the LTK
procedure.
There is great interest in utilizing CK technology for the
treatment of astigmatism. The deep penetrating cylindrical footprint of CK may
result in a more predictable astigmatic correction than previously attempted
thermokeratoplasty techniques. We have recently started an institiution review
board-approved prospective clinical trial on CK for the treatment of
astigmatism with and without hyperopia. We would like to share our initial
thoughts on four different strategies for using CK for the correction of
astigmatism alone and hyperopia with astigmatism.
Evaluation of the preoperative refraction and/or topography
identifies the flat meridian and helps to formulate a game plan for
surgery. When treating hyperopia and astigmatism, it is advisable to rotate the
corneal marks for the hyperopic part of the treatment such that the flat
meridian is left unmarked. These open areas will be used for placing additional
spots for the astigmatic correction. The placement of the spots for astigmatic
correction may be made at different optical zones with increasing astigmatic
effect as the spots are placed more centrally. Nomograms for the correction of
astigmatism that instruct on the number of spots and their optical zone
placement have yet to be developed and will require a large, controlled study
to analyze the many variables.
The second approach is to enter the operating room with a
general understanding of the astigmatism and proceed to use intraoperative
qualitative keratometry to decide the location of additional spots for
astigmatism. Based on the refraction and topography, it is advisable to
consider where you might add spots for astigmatic correction and leave these
areas open when placing your marks as previously stated above. Using a
qualitative keratometer, such as the Mastel ring (Mastel Precision, Rapid City,
SD) or something as simple as the round end of a safety pin, produces a
qualitative ring. The surgeon uses this ring to assess if there is significant
astigmatism present at the end of the procedure. The ring will be oval
(astigmatic) (Figures 3-10a and b) if significant astigmatism is present and we
place additional spots (Figures 3-11a and b) in the flat meridian until the
ring is round (spherical). The photo in Figure 3-12 shows a cornea that was
treated with CK for mixed astigmatism. It is important to make sure that the
lid speculum is not causing induced astigmatism that would influence the
intraoperative keratometry results.
The intraoperative keratometry technique was used to treat a
48-year-old female. Her uncorrected visual acuity was 20/50 with a refraction
of +2.50 -2.00 x 47, and a best-corrected visual acuity of 20/20. She underwent
CK with eight treatment spots placed at the 7-mm optical zone and two
additional treatment spots placed to produce a round keratometry ring. Her
preoperative Orbscan (Bausch & Lomb, Salt Lake City, Utah) topography
reveals the astigmatism with the flat meridian at approximately 45 degrees.
Figures 3-13a and b show the treatment pattern placed on top of the pre- and
postoperative Orbscan topography to demonstrate the placement of the spots to
correct the astigmatism by steepening the flat meridian. Her uncorrected visual
acuity is 20/20 with a refraction of +0.25 D sphere. Longer follow-up is needed
to determine stability.
|
 Figure 3-12. Clinical photo of a patient treated with CK
spots placed on flat meridian for the correction of mixed astigmatism.
|
A third approach to correcting astigmatism with CK is to
initially perform a symmetrical hyperopic correction based on the preoperative
refraction and topography. At the end of the procedure the patient is taken for
either postoperative keratometry or topography readings. Based on this
postoperative information, the patient is taken back to the operating room for
additional spots for astigmatic correction.
We have not found the immediate postoperative topography to
be useful. During the FDA hyperopia clinical trials we performed Orbscan
topography 1 hour after surgery on all patients. We did not correlate the
immediate postoperative Orbscan topography with postoperative induced
astigmatism in these patients. In contrast, using immediate postoperative
keratometry to guide astigmatic treatment has been reported to be a useful
technique (Marguerite McDonald, MD, personal communication).
|
 Figure 3-13a. Preoperative Orbscan topography
demonstrating spot pattern to treat +2.50 2.00 x 047. The arrows show the
two spots that were added on the flat meridian using intraoperative keratometry
to correct astigmatism.
|
|
 Figure 3-13b. Note the spherical central
steepening and large optical zone in the postoperative topography.
|
When treating hyperopia and astigmatism, another option is
to initially perform only the symmetrical hyperopia treatment initially. At
approximately the 1-month examination, treatment spots can be added in clinic
at the slit lamp to correct residual astigmatism. Patients usually experience
minimal postoperative discomfort with the CK procedure, which makes adding one
or two spots during a follow-up visit quite easy for the patient. The
postoperative refraction, topography, and keratometry help guide the placement
of these additional spots.
CK is an emerging thermokeratoplasty technology that
recently received approval for the treatment of mild to moderate spherical
hyperopia. Early studies suggest that CK can be used to correct astigmatism by
steepening the flat meridian. Controlled clinical trials will need to be
conducted to study the predictability and stability of CK for the correction of
astigmatism. Our CK astigmatism clinical trial is ongoing and we look forward
to presenting further results in the near future.
- Lans L. Experimentelle untersuchungen über die
entstehung von astigmatismus durch nicht perforirende corneawunden.
Albrecht von Graefes Arch Klin Exp Ophthalmol.
1898;45:117-152.
- Terrien F. Dystrophic marginale symmétrique des
deux corneés avec astigmatisme regular. Consecutif et guerison par la
cauterization ignee. Arch Ophthalmol (Paris). 1900;20:12.
- Wray C. Case of 6 D of hypermetropic astigmatism cured by
the cautery. Trans Ophthalmol Soc UK. 1914;34:109-110.
- OConnor R. Corneal cautery for high myopic
astigmatism. Am J Ophthalmol. 1933;16:337.
- Stringer H, Parr J. Shrinkage temperature of eye
collagen. Nature. 1964;204:1307.
- Caster AI. The Fyodorov technique of hyperopia correction
by thermal coagulation: a preliminary report. J Refract Surg.
1988;4:105-108.
- Neumann A, Sanders D, Salz J. Refract Corneal
Surg. 1989;5:50-54.
- Neumann A, Fyodorov S, Sanders D. Radial
thermokeratoplasty for the correction of hyperopia. Refract Corneal Surg.
1990;6:404-412.
- Neumann A, Sanders D, Raanan M, DeLuca M. Hyperopic
thermokeratoplasty: clinical evaluation. J Cataract Refract Surg.
1991;17:830-838.
- Feldman ST, Ellis W, Frucht-Pery J, Chayet A, Brown SI.
Regression of effect following radial thermokeratoplasty in humans.
Refract Corneal Surg. 1989;5:288-291.
- Thompson VM, Seiler T, Durrie DS, Cavanaugh TB.
Holmium:Yag laser thermokeratoplasty for hyperopia and astigmatism: an
overview. Refract Corneal Surg. 1993;9(2 Suppl):S134-S137.
- Mainster MA. Ophthalmic applications of infrared
lasersthermal considerations. Invest Ophthalmol Vis Sci.
1979;18:414-420.
- Seiler T, Matallana M, Bende T. Laser thermokeratoplasty
by means of a pulsed holmium:YAG laser for hyperopic correction. Refract
Corneal Surg. 1990;6:335-339.
- Brinkmann R, Koop N, Geerling G, et al. Diode laser
thermokeratoplasty: application strategy and dosimetry. J Cataract
Refract Surg. 1998;24:1195-1207.
- Bende T, Jean B, Oltrup T. Laser thermal keratoplasty
using a continuous wave diode laser. J Refract Surg.
1999;15:154-158.
- Geerling G, Koop N, Brinkmann R, et al. Continuous-wave
diode laser thermokeratoplasty: first clinical experience in blind human eyes.
J Cataract Refract Surg. 1999;25:32-40.
- Mendez A, Mendez AN. Conductive keratoplasty for the
correction of hyperopia. In: Sher NA, ed. Surgery for Hyperopia and
Presbyopia. Baltimore, Md: Williams & Wilkins; 1997:163-171.
- Koch DD, Kohnen T, Anderson JA, et al. Histologic
changes and wound healing response following 10 pulse noncontact holmium:YAG
laser thermal keratoplasty. J Refract Surg. 1996:12:623-634.
- McDonald M, Hersh PS, Manche EE, Maloney RK, Davidorf J,
Sabry M. Conductive keratoplasty for the correction of low to moderate
hyperopia: 1-year results on the first 54 eyes. Ophthalmology.
2002;109:637-649.
- Thompson VM. Holmium:YAG laser thermokeratoplasty for
correction of astigmatism. Refract Corneal Surg. 1994;10:293.
 |